- News Home
12 December 2013 1:00 pm ,
Vol. 342 ,
The iconic 125-year-old Lick Observatory on Mount Hamilton near San Jose, California, is facing the threat of closure...
Recent results from the Curiosity Mars rover have helped scientists formulate a plan for the next phase of its mission...
A new, remarkably powerful drug that cripples the hepatitis C virus (HCV) came to market last week, but it sells for $...
In pretoothbrush populations, gumlines would often be marred by a thick, visible crust of calcium phosphate, food...
Evolutionary biologists have long studied how the Mexican tetra, a drab fish that lives in rivers and creeks but has...
Victorian astronomers spent countless hours laboriously charting the positions of stars in the sky. Such sky mapping,...
In an ambitious project to study 1000 years of sickness and health, researchers are excavating the graveyard of the now...
Stefan Behnisch has won awards for designing science labs and other buildings that are smart, sustainable, and...
- 12 December 2013 1:00 pm , Vol. 342 , #6164
- About Us
Mitochondria Link Alzheimer's Disease, Down Syndrome
28 February 2002 (All day)
Alzheimer's disease almost always afflicts people older than 60, but in people with Down syndrome, Alzheimer's often strikes before age 40. Now, a team of researchers reports that breakdowns in brain cells' energy-generating mitochondria contribute to the early onset of Alzheimer's in Down syndrome patients and may spur Alzheimer's in old age as well.
Researchers suspect that people with Down syndrome are more susceptible to Alzheimer's disease because their extra copy of chromosome 21 causes them to build more of some proteins whose genes sit on that chromosome. One such gene codes for amyloid precursor protein (APP). A set of enzymes trims APP into another protein, called A?42, that is the main component of the senile plaques that characterize Alzheimer's disease. But there might be other links between the two diseases as well. For instance, Down syndrome patients have defective mitochondria, organelles that also lose efficiency as people age. Some studies have linked malfunctioning mitochondria to brain cells' inability to properly process APP, suggesting a connection to Alzheimer's.
To test how mitochondrial defects might lead to signs of Alzheimer's disease, a team led by Jorge Busciglio of the University of Connecticut, Farmington, and Bruce Yankner of Harvard Medical School in Boston examined brain cells from aborted fetuses with Down syndrome. Compared with normal cells, the Down cells accumulated more A?42 and shuttled less APP out of the cell. The team found the same pattern when they poisoned the mitochondria of normal cells--evidence, they say, that defective mitochondria allow A?42 and APP to build up inside the Down cells. What's more, the secreted form of APP is known to protect neurons from various toxins, including A?42. Reporting their results in the 28 February issue of Neuron, the researchers argue that Alzheimer's disease can result from a deadly cycle in which an excess of APP impairs mitochondria, which causes cells to secrete less of the protective form of APP, making them vulnerable to damage from A?42 accumulation.
"It's a beautifully done paper," says neuroscientist M. Flint Beal of Cornell University Medical College in New York City. "I was always a little bit skeptical [of the hypothesis that mitochondria and APP interact in a toxic feedback loop], but I'm becoming more of a believer."